Literature DB >> 15372984

In vivo model for the evaluation of molecules active towards transmissible spongiform encephalopathies.

W Ponti1, M Sala, C Pollera, D Braida, G Poli, S Bareggi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15372984     DOI： 10.1023/b:verc.0000045433.45346.1c

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN： 0165-7380            Impact factor:   2.459


× No keyword cloud information.
  5 in total

1.  CP 55,940 protects against ischemia-induced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils.

Authors:  D Braida; M Pozzi; M Sala
Journal:  Neurosci Lett       Date:  2000-12-22       Impact factor: 3.046

2.  Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil.

Authors:  M Sala; M P Leone; P Lampugnani; L Matturri; E Gori
Journal:  Eur J Pharmacol       Date:  1997-06-11       Impact factor: 4.432

Review 3.  Metal chelation as a potential therapy for Alzheimer's disease.

Authors:  M P Cuajungco; K Y Fagét; X Huang; R E Tanzi; A I Bush
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 4.  '...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease.

Authors:  Simon Melov
Journal:  Trends Neurosci       Date:  2002-03       Impact factor: 13.837

Review 5.  Drug therapy in human and experimental transmissible spongiform encephalopathy.

Authors:  Paul Brown
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910
  5 in total
  2 in total

Review 1.  Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Authors:  Marcus W Brazier; Anthony G Wedd; Steven J Collins
Journal:  Antioxidants (Basel)       Date:  2014-04-21

Review 2.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.